Argonex Inc was acquired by Millipore. Argonex is a Charlottesville, Virginia based biotechnology company devoted to developing novel immunotherapies, research tools, and technologies. Argonex's business model of combining operating companies with research operations to manage risk distinguishes Argonex as much as the scientific strength of the company's programs in antigen identification, immunotherapy, gene therapy, cell signaling, and high throughput screening. Argonex acquired Upstate Biotechnology Inc, a very early-involved SBIR firm out of Lake Placid NY
